162 related articles for article (PubMed ID: 2905651)
1. Tardive dyskinesia. Pathophysiological mechanisms and clinical trials.
Gerlach J
Encephale; 1988 Sep; 14 Spec No():227-32. PubMed ID: 2905651
[TBL] [Abstract][Full Text] [Related]
2. Effect of different neuroleptics in tardive dyskinesia and parkinsonism. A video-controlled multicenter study with chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden. Nordic Dyskinesia Study Group.
Psychopharmacology (Berl); 1986; 90(4):423-9. PubMed ID: 2880362
[TBL] [Abstract][Full Text] [Related]
3. Dogma disputed: is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity?
Jeste DV; Wyatt RJ
J Clin Psychiatry; 1981 Dec; 42(12):455-7. PubMed ID: 6118358
[TBL] [Abstract][Full Text] [Related]
4. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
Andrew HG
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
[TBL] [Abstract][Full Text] [Related]
5. Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study.
Rondot P; Bathien N
Adv Neurol; 1987; 45():361-6. PubMed ID: 2881446
[No Abstract] [Full Text] [Related]
6. Pathophysiological mechanisms underlying tardive dyskinesia.
Gerlach J
Psychopharmacology Suppl; 1985; 2():98-103. PubMed ID: 2860666
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic trial of gamma-vinyl GABA, an inhibitor of GABA transaminase, in tardive dyskinesias induced by neuroleptics].
Lambert PA; Cantiniaux P; Chabannes JP; Tell GP; Schechter PJ; Koch-Weser J
Encephale; 1982; 8(3):371-6. PubMed ID: 6137357
[TBL] [Abstract][Full Text] [Related]
8. [Physiopathology and curative treatment of tardive dyskinesia].
Wolf MA; Gautier J
Encephale; 1987; 13(5):301-8. PubMed ID: 2892663
[TBL] [Abstract][Full Text] [Related]
9. Gamma-Acetylenic GABA in tardive dyskinesia.
Casey DE; Gerlach J; Magelund G; Christensen TR
Adv Biochem Psychopharmacol; 1980; 24():577-80. PubMed ID: 6105803
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for drug-induced parkinsonism in tardive dyskinesia patients.
Hansen TE; Brown WL; Weigel RM; Casey DE
J Clin Psychiatry; 1988 Apr; 49(4):139-41. PubMed ID: 2895762
[TBL] [Abstract][Full Text] [Related]
11. Tardive dyskinesia: pathophysiology and animal models.
Casey DE
J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
[TBL] [Abstract][Full Text] [Related]
12. Tardive dyskinesia.
Gerlach J; Casey DE
Acta Psychiatr Scand; 1988 Apr; 77(4):369-78. PubMed ID: 2898870
[TBL] [Abstract][Full Text] [Related]
13. Neuroleptic medication facilitates the natural occurrence of tardive dyskinesia. A critical review.
Driesens F
Acta Psychiatr Belg; 1988; 88(3):195-205. PubMed ID: 2906780
[TBL] [Abstract][Full Text] [Related]
14. Pathway-based association analysis of genome-wide screening data suggest that genes associated with the gamma-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced, treatment-resistant tardive dyskinesia.
Inada T; Koga M; Ishiguro H; Horiuchi Y; Syu A; Yoshio T; Takahashi N; Ozaki N; Arinami T
Pharmacogenet Genomics; 2008 Apr; 18(4):317-23. PubMed ID: 18334916
[TBL] [Abstract][Full Text] [Related]
15. [Neuroleptics and nicotine].
Erdmann R
Psychiatr Prax; 1995 Nov; 22(6):223-7. PubMed ID: 8570751
[TBL] [Abstract][Full Text] [Related]
16. [Electrophysiological and pharmacological analysis of L-dopa-induced dyskinesia and tardive dyskinesia (author's transl)].
Bathien N; Rondot P; Koutlidis RM
J Physiol (Paris); 1981 Apr; 77(1):131-41. PubMed ID: 6112268
[TBL] [Abstract][Full Text] [Related]
17. Serum concentrations of haloperidol pyridinium metabolites and the relationship with tardive dyskinesia and parkinsonism: a cross-section study in psychiatric patients.
Ulrich S; Sandmann U; Genz A
Pharmacopsychiatry; 2005 Jul; 38(4):171-7. PubMed ID: 16025420
[TBL] [Abstract][Full Text] [Related]
18. The pathophysiologic basis of tardive dyskinesia.
Tarsy D; Baldessarini RJ
Biol Psychiatry; 1977 Jun; 12(3):431-50. PubMed ID: 194633
[TBL] [Abstract][Full Text] [Related]
19. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
Ghadirian AM; Annable L; Bélanger MC; Chouinard G
J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
[TBL] [Abstract][Full Text] [Related]
20. The effects of dopamine D3 agonists and antagonists in a nonhuman primate model of tardive dyskinesia.
Malik P; Andersen MB; Peacock L
Pharmacol Biochem Behav; 2004 Aug; 78(4):805-10. PubMed ID: 15301939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
